دورية أكاديمية
Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands.
العنوان: | Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands. |
---|---|
المؤلفون: | Deenen JCW; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department for Health Evidence, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Kools J; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Greco A; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Internal Medicine, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Thewissen R; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., van de Put W; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Lanser A; Patient Representative and Chairman FSHD Advocacy Group, Patient Organization for Muscular Disease Spierziekten Nederland, Lt. Gen. van Heutszlaan 6, 3743 JN, Baarn, The Netherlands., Joosten LAB; Department of Internal Medicine, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Strada Victor Babeș 8, 400347, Cluj-Napoca, Romania., Verbeek ALM; Department for Health Evidence, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., van Engelen BGM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Voermans NC; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, P. O. Box 9101, 6500 HB, Nijmegen, The Netherlands. nicol.voermans@radboudumc.nl. |
المصدر: | Acta neurologica Belgica [Acta Neurol Belg] 2024 Apr; Vol. 124 (2), pp. 559-566. Date of Electronic Publication: 2024 Jan 13. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Springer Country of Publication: Italy NLM ID: 0247035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2240-2993 (Electronic) Linking ISSN: 03009009 NLM ISO Abbreviation: Acta Neurol Belg Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2012- : Milan : Springer Original Publication: 1970-2011: Bruxelles : Acta Medica Belgica, |
مواضيع طبية MeSH: | Muscular Dystrophy, Facioscapulohumeral*/epidemiology , Muscular Dystrophy, Facioscapulohumeral*/diagnosis , Muscular Dystrophy, Facioscapulohumeral*/psychology , COVID-19*/epidemiology, Adult ; Humans ; Netherlands/epidemiology ; Pandemics ; Surveys and Questionnaires |
مستخلص: | Background: Patients with facioscapulohumeral dystrophy (FSHD) suffer from slowly progressive muscle weakness. Approximately 20% of FSHD patients end up wheelchair-dependent. FSHD patients benefit from physical activity to maintain their muscle strength as much as possible. The impact of the COVID-19 pandemic on the health of FSHD patients was unknown. Objective: This study assessed changes in daily care received, perceived psychosocial stress, and worsening of FSHD complaints in 2020. Furthermore, we compared COVID-19 infection incidence and severity of symptoms between FSHD patients and non-FSHD housemates. Methods: Three online survey rounds were sent out to all adult participants of the Dutch FSHD registry regarding daily care received, perceived psychosocial stress, COVID-19 infection rate, and COVID-19 symptoms severity. They also included COVID-19-related questions regarding the participants' housemates, which served as control group. Results: Participation rate was 210 (61%), 186 (54%), and 205 (59%) for survey 1, 2, and 3, respectively. Care reduction was reported by 42.7%, 40%, and 28.8% of the participants in the respective surveys. Perceived psychosocial stress increased in 44%, 30%, and 40% of the participants. Compared to the 197 non-FSHD housemates, the 213 FSHD patients reported more possibly COVID-19-related symptoms (27% vs. 39%, p = 0.017) of mostly minimal severity (63%). No difference in (possible) COVID-19 infection incidence rates was found (2.0% vs. 2.8%, p = 0.527). Conclusions: The COVID-19 pandemic negatively impacted care received and increased perceived psychosocial stress in FSHD patients. However, COVID-19 infection incidence in FSHD patients was similar to their non-FSHD housemates. (© 2024. The Author(s).) |
References: | Transp Res Interdiscip Perspect. 2020 Jul;6:100150. (PMID: 34171019) Acta Myol. 2019 Dec 01;38(4):207-214. (PMID: 31970319) Acta Neurol Belg. 2021 Dec;121(6):1761-1765. (PMID: 33052531) Transl Psychiatry. 2021 Jan 21;11(1):67. (PMID: 33479211) Muscle Nerve. 2021 Sep;64(3):321-327. (PMID: 34105174) Muscle Nerve. 2021 Oct;64(4):474-482. (PMID: 34296433) Muscle Nerve. 2009 Jun;39(6):729-34. (PMID: 19301367) Stroke. 1988 May;19(5):604-7. (PMID: 3363593) J Neuromuscul Dis. 2022;9(4):517-523. (PMID: 35723112) Neurology. 2020 Sep 1;95(9):e1211-e1221. (PMID: 32611642) Front Neurol. 2020 Nov 26;11:588929. (PMID: 33329336) J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417) J Neurol. 2021 Jan;268(1):20-26. (PMID: 32661716) Stroke. 1989 Jun;20(6):828. (PMID: 2728057) J Parkinsons Dis. 2020;10(4):1355-1364. (PMID: 32925108) Neurology. 2014 Nov 18;83(21):1914-22. (PMID: 25339206) Neuromuscul Disord. 2017 Aug;27(8):782-790. (PMID: 28625604) J Neuromuscul Dis. 2020;7(4):495-504. (PMID: 32925090) Int J Psychiatry Med. 2022 Jul;57(4):309-322. (PMID: 34266339) Int J Environ Res Public Health. 2022 Apr 05;19(7):. (PMID: 35410055) PLoS One. 2021 Jun 30;16(6):e0253715. (PMID: 34191825) Rev Neurol (Paris). 2020 Jun;176(6):507-515. (PMID: 32354651) J Neurol. 2021 Dec;268(12):4778-4788. (PMID: 34043041) Front Neurol. 2021 Mar 24;12:607790. (PMID: 33841296) |
فهرسة مساهمة: | Keywords: COVID-19; Epidemiology; Incidence; Neuromuscular diseases; Registries; Surveys and questionnaires |
تواريخ الأحداث: | Date Created: 20240113 Date Completed: 20240327 Latest Revision: 20240329 |
رمز التحديث: | 20240329 |
مُعرف محوري في PubMed: | PMC10965598 |
DOI: | 10.1007/s13760-023-02443-3 |
PMID: | 38218752 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2240-2993 |
---|---|
DOI: | 10.1007/s13760-023-02443-3 |